Search Results - "Suen, Hayley"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Isolation of Human CD138+ Microparticles from the Plasma of Patients with Multiple Myeloma by Krishnan, Sabna Rajeev, Luk, Frederick, Brown, Ross D, Suen, Hayley, Kwan, Yiulam, Bebawy, Mary

    Published in Neoplasia (New York, N.Y.) (01-01-2016)
    “…The confinement of multiple myeloma (MM) to the bone marrow microenvironment requires an invasive bone marrow biopsy to monitor the malignant compartment. The…”
    Get full text
    Journal Article
  2. 2

    A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma by Rajeev Krishnan, Sabna, De Rubis, Gabriele, Suen, Hayley, Joshua, Douglas, Lam Kwan, Yiu, Bebawy, Mary

    Published in Blood cancer journal (New York) (13-03-2020)
    “…Multiple myeloma is an incurable cancer of bone marrow plasma cells, with a 5-year survival rate of 43%. Its incidence has increased by 126% since 1990…”
    Get full text
    Journal Article
  3. 3

    Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma by Brown, Ross, Suen, Hayley, Favaloro, James, Yang, Shihong, Ho, P. Joy, Gibson, John, Joshua, Douglas

    Published in Oncoimmunology (01-12-2012)
    “…Trogocytosis, which results in the acquisition of myeloma cell-derived membrane proteins by T cells, and hence generates novel regulatory T cells, adds to the…”
    Get full text
    Journal Article
  4. 4

    Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma by Favaloro, James, Liyadipitiya, Tulita, Brown, Ross, Yang, Shihong, Suen, Hayley, Woodland, Narelle, Nassif, Najah, Hart, Derek, Fromm, Phillip, Weatherburn, Claire, Gibson, John, Ho, P. Joy, Joshua, Douglas

    Published in Leukemia & lymphoma (01-12-2014)
    “…Abstract Myeloid derived suppressor cells (MDSCs) are a heterogeneous population of cells that have been implicated as inhibitors of lymphopoiesis in patients…”
    Get full text
    Journal Article
  5. 5

    The T cell in Myeloma by Joshua, Douglas, Suen, Hayley, Brown, Ross, Bryant, Christian, Ho, P Joy, Hart, Derek, Gibson, John

    Published in Clinical lymphoma, myeloma and leukemia (01-10-2016)
    “…Abstract An active role for the immune system in controlling the malignant plasma cell clone in myeloma has been postulated for many years. The clinical states…”
    Get full text
    Journal Article
  6. 6

    Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state by Favaloro, James, Brown, Ross, Aklilu, Esther, Yang, Shihong, Suen, Hayley, Hart, Derek, Fromm, Phillip, Gibson, John, Khoo, Liane, Ho, P. Joy, Joshua, Douglas

    Published in Leukemia & lymphoma (01-05-2014)
    “…Abstract Discrepancies in the literature between regulatory T cell (Treg) and pro-inflammatory T helper 17 (Th17) numbers in multiple myeloma (MM) can be…”
    Get full text
    Journal Article
  7. 7

    CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis by Brown, Ross, Kabani, Karieshma, Favaloro, James, Yang, Shihong, Ho, P. Joy, Gibson, John, Fromm, Phillip, Suen, Hayley, Woodland, Narelle, Nassif, Najah, Hart, Derek, Joshua, Douglas

    Published in Blood (06-09-2012)
    “…The transfer of membrane proteins between cells during contact, known as trogocytosis, can create novel cells with a unique phenotype and altered function. We…”
    Get full text
    Journal Article
  8. 8

    Isolation of Human CD138+ Microparticles from the Plasma of Patients with Multiple Myeloma1 by Krishnan, Sabna Rajeev, Luk, Frederick, Brown, Ross D, Suen, Hayley, Kwan, Yiulam, Bebawy, Mary

    Published in Neoplasia (New York, N.Y.) (21-01-2016)
    “…The confinement of multiple myeloma (MM) to the bone marrow microenvironment requires an invasive bone marrow biopsy to monitor the malignant compartment. The…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Characterisation of the Mechanisms of Tumour-Induced Dysfunction of Clonal T Cell Expansions in Multiple Myeloma by Suen, Hayley

    Published 01-01-2017
    “…Multiple myeloma is a cancer involving malignant plasma cells in the bone marrow. Despite advances in therapy, relapse is inevitable due to residual disease…”
    Get full text
    Dissertation
  11. 11

    Protective Cytotoxic Clonal T-Cells in Myeloma Have the Characteristics of Telomere-Independent Senescence Rather Than an Exhausted or Anergic Phenotype: Implications for Immunotherapy by Suen, Hayley, Joshua, Douglas E, Brown, Ross D, Yang, Shihong, Barbaro, Pasquale Mario, Ho, P Joy, Gibson, John

    Published in Blood (06-12-2014)
    “…Dysfunctional T-cells associated with human tumors can be identified utilizing multi-parameter flow cytometry and studied for intracellular signalling…”
    Get full text
    Journal Article
  12. 12

    Phospho-Flow Cytometry Quantitation of STAT Signalling Checkpoints in Malignant and Non-Malignant Cells Identifies Patients Suitable for pSTAT3 and 5 Targeted Inhibitors by Brown, Ross D, Ho, P Joy, Joshua, Douglas E, Yang, Shihong, Bryant, Christian, Suen, Hayley, Weatherburn, Claire, Larsen, Stephen, Hart, Derek NJ, Gibson, John

    Published in Blood (03-12-2015)
    “…Background IL-6 receptor/JAK/STAT is a major signalling pathway associated with pleiotropic functions including cell transformation and proliferation. STAT3,…”
    Get full text
    Journal Article
  13. 13

    A Blood Dendritic Cell Vaccine for Acute Myeloid Leukemia by Hsu, Jennifer, Bryant, Christian, Fromm, Phillip, Papadimitrious, Michael, Orellana, Daniel, Suen, Hayley, Yang, Shihong, Weatherburn, Claire, Gasiorowski, Robin, Iland, Harry J, Brown, Ross D, Joshua, Douglas E, Ho, Phoebe Joy, Gibson, John, Clark, Georgina, Hart, Derek NJ

    Published in Blood (02-12-2016)
    “…Many acute myeloid leukemia (AML) patients achieve a complete remission (CR) with chemotherapy but relapse is common. Removal of residual disease remains the…”
    Get full text
    Journal Article
  14. 14

    Blockade of the Hedgehog Signaling Pathway by the Novel Agent NVP-LDE225 Induces Differentiation, Prevents De-Differentiation and Inhibits Proliferation of Multiple Myeloma Stem Cells in Vitro by Yang, Shihong, Brown, Ross D, Loh, Yen S, Suen, Hayley, Favaloro, James, Gibson, John, Ho, Phoebe Joy, Joshua, Douglas E

    Published in Blood (16-11-2012)
    “…Abstract 3950 Chemotherapy-resistant cancer stem cells are a major cause of relapse. It is considered that the small population of CD38++ cells which also…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Ten Year Survival in Patients with Myeloma Is Characterized by the Persistence of Immunological Control Which Is Detected by Immunological Biomarkers by Brown, Ross D, Suen, Hayley, Bryant, Christian E, Yang, Shihong, Favaloro, James, Gibson, John, Ho, P Joy, Fromm, Phillip, Hart, Derek NJ, Joshua, Douglas E

    Published in Blood (16-11-2012)
    “…Abstract 1818 There is clinical evidence for the presence of a limited degree of host-tumor control in patients with multiple myeloma (MM) but the exact…”
    Get full text
    Journal Article
  17. 17